Aerovate Therapeutics
Aerovate Therapeutics is an inhaled Version of Imatinib.
All edits
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-2 properties)
Infobox
Official Website
Official Website
Edits on 17 Mar, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 23 Feb, 2023
Katrina-Kay Pettitt
Edits on 19 Sep, 2022
Katrina-Kay Pettitt
Edits on 23 Jul, 2022
Golden AI
Edits made to:
Infobox (+1/-1 properties)
Infobox
Phone number
617-443-24000
Phone number
+161744324000
Edits on 20 Jul, 2022
Patrick Pum
Edits made to:
Infobox (+7 properties)
Infobox
Email address
info@aerovatetx.com0
Full address
930 Winter Street Suite M-500 Waltham, MA 02451, USA0
Location
Phone number
617-443-24000
Exchange
Board of Directors
CIK number
1,798,7490
IRS number
831,377,8880
Place of incorporation
SIC code
2,8340
Stock symbol
AVTE0
Edits on 12 Jun, 2022
Golden AI
Edits on 31 May, 2022
N Ni
Edits made to:
Infobox (+13 properties)
Infobox
Legal name
Aerovate Therapeutics, Inc.
Company Operating Status
Active
Email address
info@aerovatetx.com
Full address
930 Winter Street Suite M-500 Waltham, MA 02451, USA
Industry
Location
Number of Employees (ranges)
10 – 19
Phone number
617-443-2400
Pitchbook URL
Exchange
Ticker symbol
AVTE
Twitter URL
Edits on 5 Apr, 2022
Amy Sar
Edits made to:
Infobox (+3 properties)
Infobox
Industry
Website
Edits on 13 Jul, 2021
Henry Ogolla
Edits made to:
Aerovate Therapeutics
Inhaled Version of Imatinib
Edits on 1 Jul, 2021
Carla Faraguna
Edits made to:
Timeline (+1 events) (+60 characters)
Timeline
July 1, 2021
Aerovate Therapeutics made its debut on the Nasdaq Exchange.
Edits on 4 Jun, 2021
Erin Scherfner
Edits made to:
Infobox (+4 properties)
Description (+27 characters)
Aerovate Therapeutics
Inhaled Version of Imatinib
Infobox
Find more companies like Aerovate Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
